Showing results (201-210 of 375) with videos related to
Sort By:
Pageof 38
Diabetes, Obesity & Metabolism|March 13, 2008
Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti-obesity-diabetes actions of (Pro3)GIPP L McClean, V A Gault, N Irwin, et al.Diabetologia|March 19, 2013
A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed miceV K Bhat, B D Kerr, S Vasu, et al.British Journal of Pharmacology|September 3, 2013
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and miceA M McKillop, B M Moran, Y H A Abdel-Wahab, et al.Diabetologia|June 15, 2007
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria dietsV A Gault, P L McClean, R S Cassidy, et al.The Journal of Pharmacy and Pharmacology|March 3, 1999
Biphasic insulin-releasing effect of BTS 67 582 in ratsD A Storey, C J BaileyDiabetologia|November 1, 1980
Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretionC J Bailey, H Ahmed-SorourBiochemical Pharmacology|February 24, 1993
Metformin does not increase energy expenditure of brown fatA C Keates, C J BaileyThe Biochemical Journal|May 15, 1992
The esterolytic activity of epidermolytic toxinsC J Bailey, M B RedpathHormone Research|January 1, 1985
Effects of natural and synthetic estrogens and progestins on glycogen deposition in female miceL J Carrington, C J BaileyDiabete & Metabolisme|August 1, 1986
Effect of metformin on glucose metabolism in mouse soleus muscleC J Bailey, J A PuahPageof 38